Abstract
A network of European biosafety level 4 laboratories has designed the first industry-standard molecular assay for all filoviruses species, based on the strain collections of all participants. It uses 5 optimized L gene primers and 3 probes, as well as an internal control with a separate detection probe. Detection limits (probit analysis, 95% detection chance) were as follows: Zaire ebolavirus, 487 copies/mL of plasma; Sudan ebolavirus Maleo, 586 copies/mL; Sudan ebolavirus Gulu, 1128 copies/mL; Cote d'Ivoire ebolavirus, 537 copies/mL; Reston ebolavirus, 4546 copies/mL; Lake Victoria marburgvirus Musoke, 860 copies/mL; and Lake Victoria marburgvirus Ravn, 1551 copies/mL. The assay facilitates reliable detection or exclusion screening of filovirus infections. © 2007 by the Infectious Diseases Society of America. All rights reserved.
Cite
CITATION STYLE
Panning, M., Laue, T., Ölschlager, S., Eickmann, M., Becker, S., Raith, S., … Drosten, C. (2007). Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. In Journal of Infectious Diseases (Vol. 196). University of Chicago Press. https://doi.org/10.1086/520600
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.